Companies: 10,795·Total market cap: $144.5T
Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc.

PSTXNASDAQHealthcare
$9.50
+$0.00(+0.00%)
Market Cap$925933688
P/E Ratio
52W High$9.67
52W Low$1.87
Overview

Poseida Therapeutics, Inc. (PSTX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · PSTX · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.63pstx eps ttm · pstx earnings per shareEarnings history
PE Ratio (TTM)pstx pe ratio ttm · pstx price to earningsPE Ratio deep dive
Revenue (TTM)$150.9Mpstx revenue ttm · pstx annual revenueFull revenue history
Dividend YieldNo Dividenddoes pstx pay dividends · pstx dividend yieldDividend history
Shares Outstanding90.2Mpstx shares outstanding · pstx floatShares outstanding history
Next EarningsTBApstx earnings date · pstx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2023Revenue$64.7M▼ 50.37% YoY
202120222023
poseida therapeutics, inc. revenue · pstx revenue 2023
FY 2023Net Income-$123.4M▼ 92.85% YoY
202120222023
poseida therapeutics, inc. net income · pstx profit 2023
FY 2023EPS$-1.37▼ 53.93% YoY
202120222023
pstx eps · poseida therapeutics, inc. earnings per share 2023
TTM:Revenue: $150.9MNet Income: -$59.4MEPS: $-0.63View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy6 analystsis pstx a buy · pstx analyst rating
Strong Buy
0
Buy
3
Hold
3
Sell
0
Strong Sell
0
12-Month Price Target
$10.00Low
$9.50Current
$12.50Avg Target31.58% upside
$15.00High
pstx price target · pstx 12 month forecast

Total: 6 · Buy rate: 50.0%

The PSTX analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $12.50, representing +31.58% upside from the current price of $9.50.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M-0.63%
3M+241.73%
YTD+1.06%
1Y+150.66%
5Y-38.11%

About Poseida Therapeutics, Inc.

CEOMark J. Gergen
IPO DateJul 10, 2020
Employees350
CountryUS

Poseida Therapeutics, Inc. a San Diego-based clinical-stage biopharmaceutical firm established in 2014, is dedicated to advancing novel therapeutic solutions for conditions with significant unmet med…

what is poseida therapeutics, inc. · pstx stock overview · poseida therapeutics, inc. company profile · who is poseida therapeutics, inc. ceo · pstx NASDAQ · poseida therapeutics, inc. headquarters · poseida therapeutics, inc. business segments

About Stock Overview & Key Data

Poseida Therapeutics, Inc. (PSTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 10, 2020. As of the latest trading session, PSTX stock price is $9.50, with a market capitalization of $925.9M. The stock has returned +150.66% over the past 12 months and +1.06% year-to-date.

According to 6 Wall Street analysts, the consensus rating for Poseida Therapeutics, Inc. stock is Buy, with an average 12-month price target of $12.50. In fiscal year 2023, Poseida Therapeutics, Inc. reported revenue of $64.7M and net income of -$123.4M. For detailed data — including Poseida Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Poseida Therapeutics, Inc. (PSTX) stock price is $9.50. The stock is traded on NASDAQ under the ticker symbol PSTX. The 52-week range is $1.87 – $9.67.

PSTX stock pricePSTX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice